Trading on the Tel Aviv Stock Exchange (TASE) is volatile today (Monday), with the leading indexes trading relatively steadily with a slight upward bias. Perion Network stands out among the stocks, surging about 30% following the announcement that the company will be sold to Indian advertising technology company Affle for about $420 million. Gene Technology shares are up about 7%, while Gilat is down about 4.4%.
Perion’s gains come after the company, which trades on Nasdaq and the Tel Aviv Stock Exchange, signed a binding merger agreement with Affle. Under the deal, Perion shareholders will receive $11.70 in cash for each share, a price that reflects a company valuation of about $420 million and a 34.5% premium over the share’s closing price last Friday. Completion of the deal is expected to result in the delisting of the company’s shares.
Dual-listed stocks are showing mixed movements, partly due to arbitrage gaps: Tower and Palo Alto Networks are trading lower, while Teva is benefiting from a positive gap and climbing.
Meanwhile, the third-quarter earnings season is also opening this week on the local exchange. Gab-Yam published its results, reporting an 11% increase in rental revenue, which totaled about NIS 253 million. FFO attributable to shareholders rose to NIS 117 million, while net profit jumped 68% to NIS 151 million, partly due to property revaluations.

After the end of the quarter, Gab-Yam signed lease agreements with Salesforce and WeWork at the ToHa2 tower. The company’s CEO, Natalie Mashaan-Zakai, said the company continues to expect growth of about 50% in NOI and FFO by 2028.
Several prominent exchange-listed companies, including Tower, Teva and Camtek, are also expected to report earnings this week.
Against the backdrop of local trading, Asian stock exchanges and futures on Wall Street indexes are rising this morning, while oil prices are down about 3%.











